64577-63-5 (三肽-2,L-Valine,N-(2,2,2-trifluoroacetyl)-L-valyl-L-tyrosyl-)

三肽-2;三氟乙酰基三肽-2;N-(2,2,2-三氟乙酰基)-L-缬氨酰-L-酪氨酰-L-缬氨酸;

L-Valine,N-(2,2,2-trifluoroacetyl)-L-valyl-L-tyrosyl-;N-(Trifluoroacetyl)valyltyrosylvaline;TFA-VAL-TYR-VAL-OH;Tripeptide-2;Trifluoroacetyl Tripeptide-2;(S)-2-((S)-3-(4-hydroxyphenyl)-2-((S)-3-methyl-2-(2,2,2-trifluoroacetamido)butanamido)propanamido)-3-methylbutanoic acid;UNII-E6WT9V3SGO;L-Valine, N-(N-(N-(trifluoroacetyl)-L-valyl)-L-tyrosyl)-;CS-0863818;(2S)-2-[[(2S)-3-(4-hydroxyphenyl)-2-[[(2S)-3-methyl-2-[(2,2,2-trifluoroacetyl)amino]butanoyl]amino]propanoyl]amino]-3-methylbutanoic acid;CHEMBL3138715;HY-P5238;Trifluoroacetyl tripeptide-2 [INCI];N-(2,2,2-Trifluoroacetyl)-L-valyl-L-tyrosyl-L-valine;E6WT9V3SGO;L-Valine, N-(trifluoroacetyl)-L-valyl-L-tyrosyl-;L-Valine, N-(2,2,2-trifluoroacetyl)-L-valyl-L-tyrosyl-;64577-63-5;Ecm-protect;MFCD00056345;IP 2000;

SAVSLMGBKQKUAV-JYJNAYRXSA-N

1S/C21H28F3N3O6/c1-10(2)15(27-20(33)21(22,23)24)18(30)25-14(9-12-5-7-13(28)8-6-12)17(29)26-16(11(3)4)19(31)32/h5-8,10-11,14-16,28H,9H2,1-4H3,(H,25,30)(H,26,29)(H,27,33)(H,31,32)/t14-,15-,16-/m0/s1

FC(C(N[C@H](C(N[C@H](C(N[C@H](C(=O)O)C(C)C)=O)CC1C=CC(=CC=1)O)=O)C(C)C)=O)(F)F